A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Clinical trial NCT05985161 · RECRUITING

Trial details

NCT number: NCT05985161
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Wilms Tumor Rhabdoid Tumor Malignant Peripheral Nerve Sheath Tumors MPNST Nephroblastoma XPO1 Gene Mutation Solid Tumor

Start date: 2023-08-01
Primary completion: 2029-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.